CMPX vs LYB · $367.4M cap vs P/E 21, rev $40.30B
Compass Therapeutics Inc. (CMPX) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
CMPX currently screens at market cap $367.4M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the CMPX and LYB stock pages for the full models.
Not investment advice.